170 related articles for article (PubMed ID: 31894282)
1. Wnt5a/ROR1 activates DAAM1 and promotes the migration in osteosarcoma cells.
Dai B; Shen Y; Yan T; Zhang A
Oncol Rep; 2020 Feb; 43(2):601-608. PubMed ID: 31894282
[TBL] [Abstract][Full Text] [Related]
2. Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells.
Wu X; Yan T; Hao L; Zhu Y
Cancer Manag Res; 2019; 11():2803-2815. PubMed ID: 31114334
[No Abstract] [Full Text] [Related]
3. circPVT1 promotes osteosarcoma glycolysis and metastasis by sponging miR-423-5p to activate Wnt5a/Ror2 signaling.
Wan J; Liu Y; Long F; Tian J; Zhang C
Cancer Sci; 2021 May; 112(5):1707-1722. PubMed ID: 33369809
[TBL] [Abstract][Full Text] [Related]
4. Dvl2-dependent activation of Daam1 and RhoA regulates Wnt5a-induced breast cancer cell migration.
Zhu Y; Tian Y; Du J; Hu Z; Yang L; Liu J; Gu L
PLoS One; 2012; 7(5):e37823. PubMed ID: 22655072
[TBL] [Abstract][Full Text] [Related]
5. Daam1 activates RhoA to regulate Wnt5a‑induced glioblastoma cell invasion.
Liu G; Yan T; Li X; Sun J; Zhang B; Wang H; Zhu Y
Oncol Rep; 2018 Feb; 39(2):465-472. PubMed ID: 29207169
[TBL] [Abstract][Full Text] [Related]
6. Wnt5a causes ROR1 to complex and activate cortactin to enhance migration of chronic lymphocytic leukemia cells.
Hasan MK; Rassenti L; Widhopf GF; Yu J; Kipps TJ
Leukemia; 2019 Mar; 33(3):653-661. PubMed ID: 30568170
[TBL] [Abstract][Full Text] [Related]
7. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.
Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y
Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822
[TBL] [Abstract][Full Text] [Related]
9. ROR2 receptor promotes the migration of osteosarcoma cells in response to Wnt5a.
Dai B; Yan T; Zhang A
Cancer Cell Int; 2017; 17():112. PubMed ID: 29213214
[TBL] [Abstract][Full Text] [Related]
10. Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells.
Hasan MK; Yu J; Chen L; Cui B; Widhopf Ii GF; Rassenti L; Shen Z; Briggs SP; Kipps TJ
Leukemia; 2017 Dec; 31(12):2615-2622. PubMed ID: 28465529
[TBL] [Abstract][Full Text] [Related]
11. Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling.
Enomoto M; Hayakawa S; Itsukushima S; Ren DY; Matsuo M; Tamada K; Oneyama C; Okada M; Takumi T; Nishita M; Minami Y
Oncogene; 2009 Sep; 28(36):3197-208. PubMed ID: 19561643
[TBL] [Abstract][Full Text] [Related]
12. Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia.
Hasan MK; Yu J; Widhopf GF; Rassenti LZ; Chen L; Shen Z; Briggs SP; Neuberg DS; Kipps TJ
Blood; 2018 Jul; 132(2):170-178. PubMed ID: 29678828
[TBL] [Abstract][Full Text] [Related]
13. DAAM1 and DAAM2 are co-required for myocardial maturation and sarcomere assembly.
Ajima R; Bisson JA; Helt JC; Nakaya MA; Habas R; Tessarollo L; He X; Morrisey EE; Yamaguchi TP; Cohen ED
Dev Biol; 2015 Dec; 408(1):126-39. PubMed ID: 26526197
[TBL] [Abstract][Full Text] [Related]
14. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
Endo M; Doi R; Nishita M; Minami Y
J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
[TBL] [Abstract][Full Text] [Related]
15. Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways.
Karvonen H; Barker H; Kaleva L; Niininen W; Ungureanu D
Cells; 2019 Aug; 8(8):. PubMed ID: 31382410
[TBL] [Abstract][Full Text] [Related]
16. Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells.
Yu J; Chen L; Chen Y; Hasan MK; Ghia EM; Zhang L; Wu R; Rassenti LZ; Widhopf GF; Shen Z; Briggs SP; Kipps TJ
Leukemia; 2017 Dec; 31(12):2608-2614. PubMed ID: 28465528
[TBL] [Abstract][Full Text] [Related]
17. Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway.
Hasan K; Kipps TJ
Oncotarget; 2023 Mar; 14():207-209. PubMed ID: 36944183
[No Abstract] [Full Text] [Related]
18. Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.
Henry C; Llamosas E; Knipprath-Meszaros A; Schoetzau A; Obermann E; Fuenfschilling M; Caduff R; Fink D; Hacker N; Ward R; Heinzelmann-Schwarz V; Ford C
Oncotarget; 2015 Nov; 6(37):40310-26. PubMed ID: 26515598
[TBL] [Abstract][Full Text] [Related]
19. Integrin αvβ3-associated DAAM1 is essential for collagen-induced invadopodia extension and cell haptotaxis in breast cancer cells.
Yan T; Zhang A; Shi F; Chang F; Mei J; Liu Y; Zhu Y
J Biol Chem; 2018 Jun; 293(26):10172-10185. PubMed ID: 29752407
[TBL] [Abstract][Full Text] [Related]
20. Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism.
Hasan MK; Ghia EM; Rassenti LZ; Widhopf GF; Kipps TJ
Leukemia; 2021 Jun; 35(6):1621-1630. PubMed ID: 33097837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]